As mentioned earlier, there is an urgent need for the development of novel antibiotics targeting S. aureus. Fortunately, a number of new agents active against MRSA and other Gram-positive ...

The antibiotics market generated sales of US$42 ... that have been designed specifically to bind mutated targets in MRSA. As well as possessing bactericidal activity towards MRSA, the injectable ...

MRSA - or methicillin resistant staphylococcus aureus - has already become resistant to most common antibiotics, making it difficult to treat with drugs. Once it gets into the body, through wounds ...

The new research, led by the University of Sheffield, reveals MRSA has a double defence mechanism against antibiotics - this new insight offers hope in treating the life-threatening superbug and ...

Medically reviewed by Jane Kim, MD Antibiotics for pneumonia include Zithromax (azithromycin), Biaxin (clarithromycin), and ...

While many bacteria develop resistance to specific antibiotics, MRSA has acquired mechanisms that render entire classes of antibiotics ineffective, significantly complicating treatment options.

Whenever possible, the narrowest spectrum antibiotics should be used to treat an identified MRSA infection and, when it is cured, they should be discontinued as soon as possible. Furthermore ...

Important: Some strains of staph called methicillin-resistant Staphylococcus aureus (MRSA) are resistant to the most commonly used antibiotics. MRSA is often transmitted in hospitals and other ...

The US accounts for 80% to 90% of the total market for anti-MRSA antibiotics, so FDA approval is key to growing ceftobiprole's revenues, currently a minor part of its CHF 131 million ($137 million ...